Cardiovascular disease risk models and dementia or cognitive decline: a systematic review

Ruirui Jia1, Qing Wang1,2, Hengyi Huang1

  • 1School of Nursing, Lanzhou University, Lanzhou, China.

PubMed

Insights

Cardiovascular disease (CVD) risk models are linked to dementia and cognitive decline, with 14 of 15 models showing an association. Further research is needed to compare their predictive performance for cognitive disorders.

Area of Science:

  • Neurology
  • Cardiology
  • Public Health

Background:

  • Cognitive decline and dementia are increasing health concerns, particularly with an aging global population.
  • Cardiovascular disease (CVD) shares risk factors with dementia, suggesting a potential link between cardiac health and brain function.
  • Existing CVD risk models may offer insights into predicting cognitive decline.

Approach:

  • A systematic review was conducted using multiple databases (PubMed, Web of Science, etc.) from January 2014 to February 2023.
  • Included studies focused exclusively on cardiovascular disease risk models.
  • Quality assessment used the Newcastle-Ottawa scale and AHRQ criteria, adhering to PRISMA guidelines.

Key Points:

  • 22 articles were included from 9,718 screened references, summarizing 15 distinct CVD risk models.
  • Fourteen of the 15 CVD risk models demonstrated an association with dementia and cognitive decline.
  • The correlation varied based on cohort characteristics, specific risk models, cognitive tests, and study designs.

Conclusions:

  • CVD risk models are significant for public health, aiding in disease risk prediction and prevention.
  • Further cohort studies are necessary to solidify the correlation between CVD risk models and cognitive function.
  • Additional research should compare the efficacy of different CVD risk models in predicting cognitive disorders.
Abstract

Related Concept Videos

Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
120
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
500
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
200
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
17
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
33